daptomycin accordpharma 500 mg injektio-/infuusiokuiva-aine liuosta varten
accord healthcare b.v. - daptomycin - injektio-/infuusiokuiva-aine liuosta varten - 500 mg - daptomysiini
epibarb vet. 25 mg tabletti
cp-pharma handelsgesellschaft mbh - phenobarbital - tabletti - 25 mg - fenobarbitaali
epibarb vet. 60 mg tabletti
cp-pharma handelsgesellschaft mbh - phenobarbital - tabletti - 60 mg - fenobarbitaali
livogiva
theramex ireland limited - teriparatidi - osteoporoosi - kalsiumin homeostaasi - livogiva is indicated in adults. osteoporoosin hoito postmenopausaalisilla naisilla ja miehillä, joilla on lisääntynyt murtumisriski. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. hoito osteoporoosi liittyy pitkäaikaiseen, systeemiseen glukokortikoidihoitoon naisilla ja miehillä on suurempi riski saada murtuma.
daptomycin be pharma 350 mg injektio/infuusiokuiva-aine, liuosta varten
be pharma b.v. - daptomycin - injektio/infuusiokuiva-aine, liuosta varten - 350 mg - daptomysiini
daptomycin be pharma 500 mg injektio/infuusiokuiva-aine, liuosta varten
be pharma b.v. - daptomycin - injektio/infuusiokuiva-aine, liuosta varten - 500 mg - daptomysiini
bloctil 100 mg kapseli, kova
sanoswiss uab - racecadotril - kapseli, kova - 100 mg - rasekadotriili
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
sondelbay
accord healthcare s.l.u. - teriparatidi - osteoporoosi - kalsiumin homeostaasi - sondelbay is indicated in adults. osteoporoosin hoito postmenopausaalisilla naisilla ja miehillä, joilla on lisääntynyt murtumisriski. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. hoito osteoporoosi liittyy pitkäaikaiseen, systeemiseen glukokortikoidihoitoon naisilla ja miehillä on suurempi riski saada murtuma.
injexate 30 mg injektioneste, liuos, esitäytetty injektori
accord healthcare b.v. - methotrexate - injektioneste, liuos, esitäytetty injektori - 30 mg - metotreksaatti